Search Result "3CLpro"
Peptidomimetic and Peptide-Derived Against 3CLpro from Coronaviruses
Ebook: Pharmaceuticals for Targeting Coronaviruses
Volume: 1 Year: 2022
Author(s):
Doi: 10.2174/9789815051308122010007
Screening for Potential Traditional Herbal Inhibitors Against 3-Chymotrypsin- like Main Protease (3CLpro) from Four Different Coronaviruses: An in silico Approach
Journal: Coronaviruses
Volume: 2 Issue: 12 Year: 2021 Page: 12-27
Author(s): P. Singh,P. Ardra,V.R. Hariprasad,U.V. Babu,M. Rafiq,R. P. Rao
Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19
Journal: Current Pharmaceutical Design
Volume: 27 Issue: 33 Year: 2021 Page: 3577-3589
Author(s): Md. Tabish Rehman,Mohamed F. AlAjmi,Afzal Hussain
Discovery of Potential Compounds Against SARS-CoV-2 Based on3CLpro/RdRp Dual-target: An In silico Approach
Journal: Letters in Drug Design & Discovery
Volume: 20 Issue: 11 Year: 2023 Page: 1846-1860
Author(s):
Recent Advances in the Discovery of Potent Proteases Inhibitors Targeting the SARS Coronaviruses
Journal: Current Topics in Medicinal Chemistry
Volume: 21 Issue: 4 Year: 2021 Page: 307-328
Author(s): Arti Sharma,Kajal Kaliya,Sushil K. Maurya
Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery
Journal: Current Topics in Medicinal Chemistry
Volume: 20 Issue: 16 Year: 2020 Page: 1423-1433
Author(s): Ariane Sternberg,Dwight L. McKee,Cord Naujokat
Identification of Flavonoids as Potent Inhibitors Against MERS-CoV3C-like Protease
Journal: Coronaviruses
Volume: 3 Issue: 1 Year: 2022 Page: 9-17
Author(s): Fatemeh Abdi,Shahrzad Javanshir
Antiviral Potential of Medicinal Plants for the COVID-19
Journal: Anti-Infective Agents
Volume: 20 Issue: 4 Year: 2022 Page: 54-63
Author(s): Jaya P. Yadav
Identification of Novel Drug Candidates for the Inhibition of Catalytic Cleavage Activity of Coronavirus 3CL-like Protease Enzyme
Journal: Current Pharmaceutical Biotechnology
Volume: 23 Issue: 7 Year: 2022 Page: 959-969
Author(s): Arun Bahadur Gurung,Khalid Mashay Al-Anazi,Mohammad Ajmal Ali,Joongku Lee,Mohammad Abul Farah
Revealing Potential Binding Affinity of FDA Approved Therapeutics Targeting Main Protease (3CLpro) in Impairing Novel Coronavirus (SARSCoV- 2) Replication that Causes COVID-19
Journal: Coronaviruses
Volume: 1 Issue: 1 Year: 2020 Page: 98-107
Author(s): D. Sivaraman,P.S. Pradeep,S. Sundar Manoharan,C. Ramachandra Bhat,K.V. Leela,V. Venugopal